In the quiet routine of a cashier's daily life, a curtain of darkness descended over one eye — and what seemed like a need for new glasses revealed itself as a rare autoimmune assault on the nervous system itself. Tan Lee Chern, a 58-year-old Singaporean woman, was diagnosed with neuromyelitis optica spectrum disorder, a condition in which the body turns against its own central nervous system, threatening blindness and paralysis with urgent speed. Her story sits at the intersection of medical fragility and human resilience, illuminating how a single timely referral, a recently approved drug, a
The Straits Times
· May 17, 2026
· health
· 5 min read
High
Sourcing: Verified
Rare autoimmune disorder masquerades as eye problem, nearly blinds Singapore woman
Patient experienced significant vision loss and permanent partial blindness despite treatment; faces ongoing visual limitations affecting daily activities and mobility.
◉
Health & Medicine
8412 related articles
Retatrutide: Eli Lilly's Triple-Action Weight-Loss Drug Poised to Resh…
The Economic Times · 100% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight-Loss Treatment
Interesting Engineering · 99% match
Eli Lilly's Oral GLP-1 Pill Shows Promise for Diabetes and Weight Loss
TODAY · 99% match
Eli Lilly Seeks FDA Approval for Tirzepatide as Weight Loss Drug
ScienceAlert · 99% match
Moderna's personalized mRNA melanoma vaccine shows promise in preventi…
CBS News · 99% match
Related Coverage
BBC News · Aug 25
School asbestos exposure linked to woman's death at 46, family claims
A woman died from mesothelioma at 46, likely exposed to asbestos at her Cardiff school decades earlier. Her family is su…
Future of Personal Health - · Aug 25 NGS Technology Transforms Uncertain Infections Into Actionable DiagnosesHybrid-capture NGS technology helps clinicians identify pathogens in diagnostically challenging cases by simultaneously …
The Guardian · Aug 25 Shark attack survivor Leah Stewart recalls 'monster' in first interview since losing armLeah Stewart, who lost her arm in a June shark attack at Coogee Beach, recalls the traumatic encounter in her first inte…
Education News Canada · Aug 25 Systemic racism, restrictive policies block Black Canadians from blood donationBlack Canadians face systemic barriers to blood donation despite critical need for ethnicity-matched blood for sickle ce…
Geopolitical Impact
🌎
Medical case study of rare autoimmune disorder diagnosis in Singapore; no geopolitical implications identified.
Escalation Risk
low
Confidence
HIGH
Bias & Framing
⚖
Straightforward medical case study with patient narrative and expert explanation; minimal bias detected in factual health reporting.
Bias Direction
center
Confidence
MED
Human interest narrative combined with medical education; frames rare disease discovery as positive outcome through early detection and modern treatment.
masquerades as
nearly blinds
mistakenly attacks
under attack
scared and apprehensive
Perspectives from other NMOSD patients on treatment challenges or outcomes
Cost/accessibility of new targeted treatments mentioned
Epidemiological context on NMOSD prevalence in Singapore or Asia
Patient's long-term prognosis or follow-up status
Economic Lens
📈
Rare autoimmune disorder diagnosis highlights healthcare system efficiency but has minimal direct economic impact; primarily a medical/public health matter with limited macroeconomic implications.
Market Signal
neutral
Confidence
LOW
Healthcare/Pharmaceuticals
Medical diagnostics and imaging
Specialty medicine and neurology services
Consumers benefit from early diagnostic capabilities and access to specialized treatment for rare diseases. However, NMOSD treatments are typically expensive biologics, potentially increasing out-of-pocket costs for affected patients and healthcare system expenditures.
May prompt healthcare policy discussions around: (1) funding for rare disease diagnosis and treatment in public healthcare systems; (2) specialist referral pathways and inter-hospital coordination; (3) coverage decisions for expensive biologic therapies for rare autoimmune conditions; (4) public health awareness campaigns for atypical disease presentations.